Evogene Posts 31 Percent Q3 Revenue Growth | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Evogene today reported a 31 percent revenue spike for the third quarter ended Sept. 30.

The Rehovot, Israel-based plant genomics firm reported total revenues of $3.4 million for the quarter compared to $2.6 million for the third quarter of 2010.

Evogene's net loss for the quarter was $2.3 million, or $.07 per share, versus a loss of $3.6 million, or $.12 per share, for the third quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.